Tea consumption enhances endothelial-dependent vasodilation; a meta-analysis

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Ras, Rouyanne T ^a   Zock, Peter L ^a   Draijer, Richard ^a  

^a UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLACK TEA EXTRACT; GREEN TEA EXTRACT; PLACEBO;

ARTERY BLOOD FLOW; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR RISK; FLUID INTAKE; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SYSTEMATIC REVIEW; TEA; VASCULAR ENDOTHELIUM; VASODILATATION; ADULT; BEVERAGE; BLOOD RHEOLOGY; FEMALE; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PUBLISHING;

ADULT; BEVERAGES; FEMALE; HEMORHEOLOGY; HUMANS; MALE; MIDDLE AGED; PUBLICATION BIAS; TEA; VASODILATION;

EID: 79952355001     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016974     Document Type: Article

References (62)

1. Peters U, Poole C, Arab L, (2001) Does tea affect cardiovascular disease? A meta-analysis. Am J Epidemiol 154: 495-503.
2. Arab L, Liu W, Elashoff D, (2009) Green and Black Tea Consumption and Risk of Stroke. A Meta-Analysis. Stroke 2009.
3. Vita JA, (2003) Tea consumption and cardiovascular disease: effects on endothelial function. J Nutr 133: 3293S-7S.
4. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA, (2003) The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42: 1149-60.
5. Ross R, (1999) Atherosclerosis: an inflammatory disease. N Engl J Med 340: 115-26.
6. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE, (1994) Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 24: 1468-74.
7. Bonetti PO, Lerman LO, Lerman A, (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23: 168-75.
8. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, et al. (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340: 1111-5.
9. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, et al. (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39: 257-65.
10. Shimbo D, Grahame-Clarke C, Miyake Y, Rodriguez C, Sciacca R, et al. (2007) The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis 192: 197-203.
11. Fathi R, Haluska B, Isbel N, Short L, Marwick TH, (2004) The relative importance of vascular structure and function in predicting cardiovascular events. J Am Coll Cardiol 43: 616-23.
12. Frick M, Suessenbacher A, Alber HF, Dichtl W, Ulmer H, et al. (2005) Prognostic value of brachial artery endothelial function and wall thickness. J Am Coll Cardiol 46: 1006-10.
13. Gokce N, Keaney JF, Hunter LM, Watkins MT, Nedeljkovic ZS, et al. (2003) Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 41: 1769-75.
14. Brevetti G, Silvestro A, Schiano V, Chiariello M, (2003) Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 108: 2093-8.
15. Karatzis EN, Ikonomidis I, Vamvakou GD, Papaioannou TG, Protogerou AD, et al. (2006) Long-term prognostic role of flow-mediated dilatation of the brachial artery after acute coronary syndromes without ST elevation. Am J Cardiol 98: 1424-8.
16. Chan SY, Mancini GB, Kuramoto L, Schulzer M, Frohlich J, et al. (2003) The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol 42: 1037-43.
17. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, et al. (2009) Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 120: 502-9.
18. Shechter M, Issachar A, Marai I, Koren-Morag N, Freinark D, et al. (2009) Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease. Int J Cardiol 134: 52-8.
19. Duffy SJ, Keaney JF Jr, Holbrook M, Gokce N, Swerdloff PL, et al. (2001) Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 104: 151-6.
20. Hodgson JM, Puddey IB, Burke V, Watts GF, Beilin LJ, (2002) Regular ingestion of black tea improves brachial artery vasodilator function. Clin Sci (Lond) 102: 195-201.
21. Hirata K, Shimada K, Watanabe H, Otsuka R, Tokai K, et al. (2004) Black tea increases coronary flow velocity reserve in healthy male subjects. Am J Cardiol 93: 1384-1388.
22. Hodgson JM, Burke V, Puddey IB, (2005) Acute effects of tea on fasting and postprandial vascular function and blood pressure in humans. J Hypertens 23: 47-54.
23. Jochmann N, Lorenz M, Krosigk A, Martus P, Bohm V, et al. (2008) The efficacy of black tea in ameliorating endothelial function is equivalent to that of green tea. Br J Nutr 99: 863-8.
24. Lorenz M, Jochmann N, Krosigk A, Martus P, Baumann G, et al. (2007) Addition of milk prevents vascular protective effects of tea. Eur Heart J 28: 219-23.
25. Kim W, Jeong MH, Cho SH, Yun JH, Chae HJ, et al. (2006) Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers. Circ J 70: 1052-7.
26. Alexopoulos N, Vlachopoulos C, Aznaouridis K, Baou K, Vasiliadou C, et al. (2008) The acute effect of green tea consumption on endothelial function in healthy individuals. Eur J Cardiovasc Prev Rehabil; 15: 300-5.
27. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, et al. (2008) Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 88: 38-50.
28. Park CS, Kim W, Woo JS, Ha SJ, Kang WY, et al. (2009) Green tea consumption improves endothelial function but not circulating endothelial progenitor cells in patients with chronic renal failure. Int J Cardiol doi:10.1016/j.ijcard.2009.09.471.
29. Verhagen AP, de Vet HC, de Bie RA, Kessels AG, Boers M, et al. (1998) The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 51: 1235-41.
30. Follmann D, Elliott P, Suh I, Cutler J, (1992) Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 45: 769-73.
31. de Bree A, van Mierlo LA, Draijer R, (2007) Folic acid improves vascular reactivity in humans: a meta-analysis of randomized controlled trials. Am J Clin Nutr 86: 610-7.
32. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials; 7: 177-88.
33. Van Houwelingen HC, Arends LR, Stijnen T, (2002) Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 21: 589-624.
34. Cochran WG, (1954) The combination of estimates from different experiments. Biometrics 10: 101-29.
35. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-58.
36. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-60.
37. Thompson SG, Sharp SJ, (1999) Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 18: 2693-708.
38. Thompson SG, Higgins JP, (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21: 1559-73.
39. Egger M, Davey SG, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-34.
40. Ardalan MR, (2007) Black tea improves endothelial function in renal transplant recipients. Transplantation-proceedings 39: 1139-42.
41. Grassi D, Mulder T, Draijer D, Desideri G, Molhuizen H, et al. (2009) Black tea consumption dose-dependently improves flow-mediated dilation in healthy males. Journal of Hypertension 27: 774-81.
42. Huang AL, Silver AE, Shvenke E, Schopfer DW, Jahangir E, et al. (2007) Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol 27: 2113-9.
43. Kitta Y, Obata JE, Nakamura T, Hirano M, Kodama Y, et al. (2009) Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol 53: 323-30.
44. Modena MG, Bonetti L, Coppi F, Bursi F, Rossi R, (2002) Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol 40: 505-10.
45. Widlansky ME, (2007) Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. Journal-of-the-American-College-of-Nutrition 26: 95-102.
46. Papamichael CM, Aznaouridis KA, Karatzis EN, Karatzi KN, Stamatelopoulos KS, et al. (2005) Effect of coffee on endothelial function in healthy subjects: the role of caffeine. Clin Sci (Lond) 109: 55-60.
47. Manach C, Williamson G, Morand C, Scalbert A, Remesy C, (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81: 230S-42S.
48. Chow HH, Hakim IA, Vining DR, Crowell JA, Ranger-Moore J, et al. (2005) Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res 11: 4627-33.
49. Astill C, Birch MR, Dacombe C, Humphrey PG, Martin PT, (2001) Factors affecting the caffeine and polyphenol contents of black and green tea infusions. J Agric Food Chem 49: 5340-7.
50. Lakenbrink C, Lapczynski S, Maiwald B, Engelhardt UH, (2000) Flavonoids and other polyphenols in consumer brews of tea and other caffeinated beverages. J Agric Food Chem 48: 2848-52.
51. Grassi D, Aggio A, Onori L, Croce G, Tiberti S, et al. (2008) Tea, flavonoids, and nitric oxide-mediated vascular reactivity. J Nutr 138: 1554S-60S.
52. Fitzpatrick DF, Hirschfield SL, Ricci T, Jantzen P, Coffey RG, (1995) Endothelium-dependent vasorelaxation caused by various plant extracts. J Cardiovasc Pharmacol 26: 90-5.
53. Loke WM, Hodgson JM, Proudfoot JM, McKinley AJ, Puddey IB, et al. (2008) Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr 88: 1018-25.
54. Persson IA, Josefsson M, Persson K, Andersson RG, (2006) Tea flavanols inhibit angiotensin-converting enzyme activity and increase nitric oxide production in human endothelial cells. J Pharm Pharmacol 58: 1139-44.
55. Anter E, Thomas SR, Schulz E, Shapira OM, Vita JA, et al. (2004) Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols. J Biol Chem 279: 46637-43.
56. Lorenz M, Wessler S, Follmann E, Michaelis W, Dusterhoft T, et al. (2004) A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J Biol Chem 279: 6190-5.
57. Schewe T, Steffen Y, Sies H, (2008) How do dietary flavanols improve vascular function? A position paper. Arch Biochem Biophys 476: 102-6.
58. Thijssen DHJ, Black MA, Pyke KE, Padilla J, Atkinson G, et al. (2010) Assessment of flow mediated dilation (FMD) in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol doi:10.1152/ajpheart.00471.2010.
59. De Roos NM, Bots ML, Schouten EG, Katan MB, (2003) Within-subject variability of flow-mediated vasodilation of the brachial artery in healthy men and women: implications for experimental studies. Ultrasound Med Biol 29: 401-6.
60. Herrington DM, Fan L, Drum M, Riley WA, Pusser BE, et al. (2001) Brachial flow-mediated vasodilator responses in population-based research: methods, reproducibility and effects of age, gender and baseline diameter. J Cardiovasc Risk 8: 319-28.
61. Doshi SN, Naka KK, Payne N, Jones CJ, Ashton M, et al. (2001) Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. Clin Sci (Lond); 101: 629-35.
62. Pyke and Tschakovsky (2005) The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function. J Physiol 568: 357-369.